For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231012:nRSL8486Pa&default-theme=true
RNS Number : 8486P Tristel PLC 12 October 2023
Tristel plc
("Tristel" or the "Company")
Additional Investor Presentation
Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that the Company will deliver a Company Overview presentation at a
hybrid event in London hosted by the UK Individual Shareholders' Society
(ShareSoc) on Thursday 19 October 2023 and available to ShareSoc members via
the link below:
https://www.sharesoc.org/sharesoc-walbrook-pr-healthcare-companies-hybrid-event-london-19-october-2023-5pm/
(https://www.sharesoc.org/sharesoc-walbrook-pr-healthcare-companies-hybrid-event-london-19-october-2023-5pm/)
Paul Swinney, Chief Executive Officer will deliver an "in-person" presentation
which will also be streamed live (and recorded), allowing ShareSoc members to
watch virtually.
Preliminary results for the year ended 30 June 2023 will be announced on
Monday 16 October 2023 and no new material information will be disclosed in
the presentation.
As previously announced the Company will also provide both an online
presentation and in-person presentation open to all interested investors on
Monday 16 October 2023. Further details can be found here:
https://tristelgroup.com/wp-content/uploads/2023/09/TSTL-Notice-of-results-FINAL.pdf
(https://tristelgroup.com/wp-content/uploads/2023/09/TSTL-Notice-of-results-FINAL.pdf)
For further information please contact:
Tristel plc Tel: 01638 721 500
Paul Swinney, Chief Executive Officer
Liz Dixon, Chief Financial Officer
Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com
Paul McManus Mob: 07980 541 893
Lianne Applegarth Mob: 07584 391 303
Charlotte Edgar Mob: 07884 664 686
Cavendish Capital Markets Limited Tel: 020 7220 0500
Geoff Nash/Charlie Beeson (Corporate Finance)
Sunila de Silva (ECM)
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRAFFIFWFEDSEIS